Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
February 7, 2024
Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
February 6, 2024
Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
February 5, 2024
Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 2, 2024
Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
January 5, 2024
Jasper Therapeutics, Inc. Announces Reverse Stock Split
January 2, 2024
Displaying 11 - 16 of 16